t
gf

Sphere Fluidics News:

2010 News    2011 News    2012 News

2013 News    2014 News

 

2015 NEWS

26th March 2015: Sphere Fluidics Awarded Almost £1.6 million in AMSCI Biologics Manufacturing Grant
Sphere Fluidics has won £1.6 million of a BIS £6.2 million Advanced Manufacturing Supply Chain Initative grant. The grant was led by the Centre for Process Innovation and other syndicate members included UCB, Lonza, Horizon Discovery and Alcyomics. "I am very pleased to win this grant", said Dr Marian Rehak (R&D Director of Sphere Fluidics). "The syndicate aims to incorporate Sphere Fluidics' Cyto-Mine platform into the biologics supply chain and revolutionise it.". Other information can be found here: www.uk-cpi.com/news/cpi-led-uk-biotech-consortium-secures-6-2m-government-investment/

17th March 2015: Sphere Fluidics a Finalist in Business Weekly Life Sciences Innovation Award
Sphere Fluidics has been nominated as a finalist in the East of England's Business Weekly 2015 Life Sciences Innovation Award. "I am very pleased that our innovative, single cell analysis platform has been recognised in the biotech community" said Dr Rob Marchmont (Commercial Director). "AstraZeneca and MedImmune sponsored the award and Sphere Fluidics is a member of an exciting group of finalists".

16th March 2015: Sphere Fluidics Pitches to Investors at Cambridge Enterprise Venture Partners Event
Sphere Fluidics' CEO (Dr Frank F.Craig) will be pitching to a room of circa 50 investors at the Cambridge Enterprise Venture Partners dinner at Christ College, Cambridge (UK) on 17th March 2015. "I will be reviewing the significant commercial progress we are now experiencing plus outlining the Cyto-Mine program and the major new markets that we have identified to our current (and potentially new) investors. This marks the start of an exciting year of accelerated growth for Sphere Fluidics".

12th March 2015: Sphere Fluidics Files Cyto-MIne for a US Trademark
Sphere Fluidics has submitted theTrademark for Cyto-Mine for filing in the US. Cyto-Mine is a novel single cell assay and monoclonality assurance system. "Cyto-Mine is creating a lot of excitement in the industry and the US is our biggest market. Thus, it is important for us to get IP protection in that region" said Dr Frank F. Craig (CEO). "We aim to have the trademark awarded late this year".

7th March 2015: Sphere Fluidics Exhibiting at Bio-Europe 2015 in Paris
Dr Rob Marchmont (Commercial Director) and Dr Frank F. Craig (CEO) will be attending Bio-Europe Spring 2015 in Paris (France) on March 9th-11th 2015. "We will be exhibiting at the UK Pavilion and also attending a number of biopartnering meetings with leading companies." said Dr Marchmont. "Bio-Europe is a great conference and I look forward to meeting key companies and establishing new collaborations at the meeting." said Dr Craig. Bio-Europe conference information can be found here: www.ebdgroup.com/bes/index.php

5th March 2015. Sphere Fluidics Named as one of the UK's Top Disruptive SMEs
Sphere Fluidics has been nominated by Real Business as one of the UK's Top 50 Disruptive SMEs. This was part of the Everline Future 50 competition. Dr Rob Marchmont (Commercial Director) attended the awards ceremony and stated "It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary". Information on the award can be found here: realbusiness.co.uk/article/29477-sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive_29477

28th February 2015: Sphere Fluidics to Present at Biopharmaceutical Symposium
Sphere Fluidics' CEO (Dr Frank F. Craig) will be presenting at a KTN Biopharmaceutical Analytical Group Symposium to be held in Leeds (UK) on the 4th-5th of March 2015. The title of his talk will be: "Cyto-Mine Single Cell Analysis Technology for Accelerated Biopharmaceutical Discovery and Development". He said, "This is an excellent forum that brings together leaders in the biopharmaceutical discovery and tools field. I will present on progress of Cyto-Mine development and use of picodroplets with single cells". Conference information can be found here: www.enterpriseeuropeeast.org.uk/eox/events/register.as

10th February 2015: Sphere Fluidics Attending The Royal Society's "Labs to Riches" Event in London
Sphere Fluidics' CEO (Dr Frank F. Craig) will be attending The Royal Society's prestigious "Labs to Riches" event in London on the 11th Feb 2015. "This is an annual event where science, business ands society leaders get together for annual awards and networking. It is an excellent forum for showcasing science, new companies and bringing together companies with potential investors. I look forward to interesting discussions", he said. More information can be found here: royalsociety.org/grants/labs-to-riches/

21st January 2015: Sphere Fluidics attending Industrial Biotechnology Showcase 2015 in London
Dr Frank F. Craig (CEO of Sphere Fluidics Limited) will be attending the InnovateUK network conference on Industrial Biotechnology on Feb 11th-12th 2015 in London. "This is an excellent forum for industry and academia to get together and share thoughts on industrialising technology for (bio)pharmaceutical manufacture, enzyme production and bioprocessing etc. Our new single cell analysis platform (Cyto-Mine) will have a large impact on such areas as well as upstream in discovery and development. I am also looking forward to meeting with other industry colleagues at the biopartnering aspect at the conference". Conference information can be found here: connect.innovateuk.org/web/industrial-biotechnology

gf
link to home page link to science and technology page link to services page link to products page link to leadership page link to news page link to careers pagelink to contact page link to management page